Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 4,862 | 4,893 | 4,843 | 4,847 | 4,949 |
| Accounts receivable | -61 | -10,961 | 3,387 | -4,820 | 13,857 |
| Accounts payable and accrued liabilities | -74 | 651 | 6,877 | -6,594 | 1,582 |
| Other Working Capital | 22,480 | -12,052 | 5,781 | -10,761 | 19,431 |
| Other Operating Activity | 2,907 | 34,498 | -5,045 | -1,270 | -25,507 |
| Operating Cash Flow | $30,114 | $17,029 | $15,843 | $-18,598 | $14,312 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -281 | 0 | 0 | 0 | -299 |
| Purchase Of Investment | -84,692 | -143,014 | -196,866 | -121,260 | -144,287 |
| Sale Of Investment | 123,970 | 132,571 | 158,372 | 170,505 | 138,089 |
| Other Investing Activity | 226 | -129 | -128 | -12 | 240 |
| Investing Cash Flow | $39,223 | $-10,572 | $-38,622 | $49,233 | $-6,257 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,030 | -2,958 | -3,223 | -2,778 | -6,543 |
| Common Stock Repurchased | -21,804 | 0 | -6,134 | -12,301 | N/A |
| Other Financing Activity | 1,788 | 236 | 1,084 | 28 | 966 |
| Financing Cash Flow | $-23,046 | $-2,722 | $-8,273 | $-15,051 | $-5,577 |
| Beginning Cash Position | 37,142 | 33,407 | 64,459 | 48,875 | 46,397 |
| End Cash Position | 83,433 | 37,142 | 33,407 | 64,459 | 48,875 |
| Net Cash Flow | $46,291 | $3,735 | $-31,052 | $15,584 | $2,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | 30,114 | 17,029 | 15,843 | -18,598 | 14,312 |
| Capital Expenditure | -56 | -129 | -84 | -12 | -59 |
| Free Cash Flow | 30,058 | 16,900 | 15,759 | -18,610 | 14,253 |